Paper36979768
Epigallocatechin Gallate (EGCG), an Active Phenolic Compound of Green Tea, Inhibits Tumor Growth of Head and Neck Cancer Cells by Targeting DNA Hypermethylation.
Agarwal A and 4 others. Biomedicines, 2023. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. Epigallocatechin Gallate (EGCG), an Active Phenolic Compound of Green Tea, Inhibits Tumor Growth of Head and Neck Cancer Cells by Targeting DNA Hypermethylation. Papers, record 36979768. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979768
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Epigallocatechin Gallate (EGCG), an Active Phenolic Compound of Green Tea, Inhibits Tumor Growth of Head and Neck Cancer Cells by Targeting DNA Hypermethylation.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 EY012601 | NEI NIH HHS | United States | R01EY012601 | PubMed | NIH RePORTER |
| R01 EY032753 | NEI NIH HHS | United States | R01EY032753 | PubMed | NIH RePORTER |
| R01 EY025383 | NEI NIH HHS | United States | R01EY025383 | PubMed | NIH RePORTER |
| R01 EY028037 | NEI NIH HHS | United States | R01EY028037 | PubMed | NIH RePORTER |
| R01 EY028858 | NEI NIH HHS | United States | R01EY028858 | PubMed | NIH RePORTER |
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8331684 | Increased cytosine DNA-methyltransferase activity during colon cancer progression. | J Natl Cancer Inst | 1993 | https://conductscience.org/library/papers/8331684 | PubMed |
| 2 | 8247133 | Role for DNA methylation in genomic imprinting. | Nature | 1993 | https://conductscience.org/library/papers/8247133 | PubMed |
| 3 | 10655057 | Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. | Nat Genet | 2000 | https://conductscience.org/library/papers/10655057 | PubMed |
| 4 | 32114424 | Epigenetic alterations in cancer. | Front Biosci (Landmark Ed) | 2020 | https://conductscience.org/library/papers/32114424 | PubMed |
| 5 | 12402499 | CDKs and CKIs: molecular targets for tissue remodelling. | Nat Rev Drug Discov | 2002 | https://conductscience.org/library/papers/12402499 | PubMed |
| 6 | 27057123 | A simple practice guide for dose conversion between animals and human. | J Basic Clin Pharm | 2016 | https://conductscience.org/library/papers/27057123 | PubMed |
| 7 | 23814491 | Prostaglandin E2 Promotes UV radiation-induced immune suppression through DNA hypermethylation. | Neoplasia | 2013 | https://conductscience.org/library/papers/23814491 | PubMed |
| 8 | 17662938 | Cellular senescence in cancer and aging. | Cell | 2007 | https://conductscience.org/library/papers/17662938 | PubMed |
| 9 | 18413741 | Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. | Cancer Res | 2008 | https://conductscience.org/library/papers/18413741 | PubMed |
| 10 | 16203797 | Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. | Clin Cancer Res | 2005 | https://conductscience.org/library/papers/16203797 | PubMed |
| 11 | 36633525 | Cancer statistics, 2023. | CA Cancer J Clin | 2023 | https://conductscience.org/library/papers/36633525 | PubMed |
| 12 | 35054091 | Regular Intake of Green Tea Polyphenols Suppresses the Development of Nonmelanoma Skin Cancer through miR-29-Mediated Epigenetic Modifications. | J Clin Med | 2022 | https://conductscience.org/library/papers/35054091 | PubMed |
| 13 | 31906785 | Global Burden of Head and Neck Cancer: Economic Consequences, Health, and the Role of Surgery. | Otolaryngol Head Neck Surg | 2020 | https://conductscience.org/library/papers/31906785 | PubMed |
| 14 | 11333864 | Methylation matters. | J Med Genet | 2001 | https://conductscience.org/library/papers/11333864 | PubMed |
| 15 | 17570133 | Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG. | J Cell Biochem | 2008 | https://conductscience.org/library/papers/17570133 | PubMed |
| 16 | 18925932 | Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper. | BMC Med Imaging | 2008 | https://conductscience.org/library/papers/18925932 | PubMed |
| 17 | 27194046 | Epigenetic Determinants of Cancer. | Cold Spring Harb Perspect Biol | 2016 | https://conductscience.org/library/papers/27194046 | PubMed |
| 18 | 35833037 | A Study of Head and Neck Cancer Patients with Reference to Tobacco Use, Gender, and Subsite Distribution. | South Asian J Cancer | 2022 | https://conductscience.org/library/papers/35833037 | PubMed |
| 19 | 15978859 | Methylation of tumor suppressor genes p16(INK4a), p27(Kip1) and E-cadherin in carcinogenesis. | Oral Oncol | 2006 | https://conductscience.org/library/papers/15978859 | PubMed |
| 20 | 19450526 | Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary. | Mol Cell | 2009 | https://conductscience.org/library/papers/19450526 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953404 | Metabolic control of methylation landscapes in cancer growth and plasticity: targeting the epigenetic-metabolic axis with natural compounds and emerging therapies. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42953404 | PubMed |
| 42839965 | Epigenetic repurposing of carbohydrate metabolic inhibitors for insulin resistance: targeting DNMT1 and HDAC3 for β-cell restoration. | Front Epigenet Epigenom | 2025 | https://conductscience.org/library/papers/42839965 | PubMed |
| 42589007 | Nutritional Modulation of Epigenetic Responses to Heat Stress in Farm Animals: Evidence, Limitations and Perspectives. | Animals (Basel) | 2026 | https://conductscience.org/library/papers/42589007 | PubMed |
| 42453404 | Dual-pathway induction of pyroptosis via biomineralized-like nanoparticles trigger potent immunotherapy against tumor. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42453404 | PubMed |
| 42373923 | The power of phytochemicals in cancer chemoprevention through multi-target modulation of oncogenic signaling pathways. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42373923 | PubMed |
| 42357499 | Changes in HDAC Expression and Activity by Oolongtheanin Digallate and Theasinensins and the Onset of Apoptosis. | Molecules | 2026 | https://conductscience.org/library/papers/42357499 | PubMed |
| 42353630 | Plant Bioactive Constituents and Their Potential Benefits in HPV-Positive Oropharyngeal Squamous Cell Carcinoma-A Narrative Review. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42353630 | PubMed |
| 42298579 | The nutrigenomic-epigenetic axis in cancer: from dietary bioactives to precision oncology. | Nutr Metab (Lond) | 2026 | https://conductscience.org/library/papers/42298579 | PubMed |
| 42222507 | Integrative single-cell and bulk transcriptomic analysis identifies lesion-associated gene signatures for prognostic stratification and therapeutic guidance in head and neck squamous cell carcinoma. | Biochem Biophys Rep | 2026 | https://conductscience.org/library/papers/42222507 | PubMed |
| 42122795 | Biochemical Profiles, Mineral Accumulation, and Water-Soluble Fluoride Traits of 65 Tea (Camellia sinensis) Cultivars: For Germplasm Screening and Quality Evaluation. | Plants (Basel) | 2026 | https://conductscience.org/library/papers/42122795 | PubMed |
| 41817235 | Interactions between nutrition and the epigenome: how can it be harnessed for public health? | Future Sci OA | 2026 | https://conductscience.org/library/papers/41817235 | PubMed |
| 41585119 | A scientometric study on methylation modification and identification of related genes in oral potentially malignant disorders and oral cancer. | J Dent Sci | 2026 | https://conductscience.org/library/papers/41585119 | PubMed |
| 41126075 | Association of dietary total antioxidant capacity with KRAS gene mutation in metastatic colorectal cancer patients: a case-control study. | Genes Nutr | 2025 | https://conductscience.org/library/papers/41126075 | PubMed |
| 41104886 | Therapeutic potentials of plant‑based antioxidants on colorectal cancer: Challenges and perspectives (Review). | Int J Oncol | 2025 | https://conductscience.org/library/papers/41104886 | PubMed |
| 40964173 | Polyphenols bind G4-Quadruplex structures and act as epigenetic modifiers with anti-cancer effects. | EXCLI J | 2025 | https://conductscience.org/library/papers/40964173 | PubMed |
| 40935853 | The emerging intertwined activities of metabolism and epigenetics unveils culprits and prospects in cancer. | Exp Mol Med | 2025 | https://conductscience.org/library/papers/40935853 | PubMed |
| 40691179 | Dietary hormesis: beyond nutrition and energy supply. | NPJ Sci Food | 2025 | https://conductscience.org/library/papers/40691179 | PubMed |
| 40325471 | Recent advances on gene-related DNA methylation in cancer diagnosis, prognosis, and treatment: a clinical perspective. | Clin Epigenetics | 2025 | https://conductscience.org/library/papers/40325471 | PubMed |
| 40169434 | Mesoporous polydopamine nanoparticles coated with metal-polyphenol networks for demethylation therapy of lung cancer. | Med Oncol | 2025 | https://conductscience.org/library/papers/40169434 | PubMed |
| 40004944 | Polyphenol-Based Prevention and Treatment of Cancer Through Epigenetic and Combinatorial Mechanisms. | Nutrients | 2025 | https://conductscience.org/library/papers/40004944 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36979768
GET https://conductscience.org/api/papers/v1/36979768/references?page=2